Renaissance Technologies’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-324,600
| Closed | -$8.75M | – | 4538 |
|
|
2022
Q4 | $8.75M | Buy |
324,600
+36,100
| +13% | +$950K | 0.01% | 1171 |
|
|
2022
Q3 | $5.18M | Buy |
288,500
+9,700
| +3% | +$155K | 0.01% | 1417 |
|
|
2022
Q2 | $3.46M | Buy |
278,800
+57,600
| +26% | +$636K | ﹤0.01% | 1813 |
|
|
2022
Q1 | $2.95M | Buy |
221,200
+65,500
| +42% | +$878K | ﹤0.01% | 1938 |
|
|
2021
Q4 | $2.42M | Sell |
155,700
-90,900
| -37% | -$1.74M | ﹤0.01% | 1986 |
|
|
2021
Q3 | $5.53M | Buy |
246,600
+19,604
| +9% | +$430K | 0.01% | 1400 |
|
|
2021
Q2 | $5.17M | Buy |
+226,996
| New | +$4.78M | 0.01% | 1612 |
|
|
2021
Q1 | – | Sell |
-111,700
| Closed | -$3.08M | – | 3839 |
|
|
2020
Q4 | $3.08M | Sell |
111,700
-99,200
| -47% | -$1.93M | ﹤0.01% | 1876 |
|
|
2020
Q3 | $2.96M | Sell |
210,900
-358,366
| -63% | -$6.67M | ﹤0.01% | 1883 |
|
|
2020
Q2 | $11.7M | Buy |
569,266
+540,566
| +1,884% | +$7.35M | 0.01% | 1129 |
|
|
2020
Q1 | $217K | Buy |
+28,700
| New | +$322K | ﹤0.01% | 3088 |
|
|
2019
Q3 | – | Sell |
-20,300
| Closed | -$184K | – | 3806 |
|
|
2019
Q2 | $184K | Buy |
+20,300
| New | +$303K | ﹤0.01% | 3317 |
|
|
2018
Q3 | – | Sell |
-13,000
| Closed | -$297K | – | 3630 |
|
|
2018
Q2 | $297K | Buy |
+13,000
| New | +$284K | ﹤0.01% | 2966 |
|
|
2017
Q4 | – | Sell |
-24,759
| Closed | -$383K | – | 3549 |
|
|
2017
Q3 | $383K | Sell |
24,759
-1,952
| -7% | -$23.7K | ﹤0.01% | 2850 |
|
|
2017
Q2 | $313K | Buy |
+26,711
| New | +$331K | ﹤0.01% | 2893 |
|
Other funds holding MYOV
Renaissance Technologies's MYOV Position: Q1 2023 in Review
Renaissance Technologies sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 324,600 shares — an estimated $8.75M sold.
Renaissance Technologies first reported a position in MYOV in Q2 2017 and held it in 15 quarters. The position peaked at $11.7M in Q2 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Renaissance Technologies reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Renaissance Technologies sold 324,600 Myovant Sciences Ltd. shares in Q1 2023, an estimated $8.75M.
- Renaissance Technologies first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 15 quarters.
- Renaissance Technologies's Myovant Sciences Ltd. position peaked at $11.7M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.